SCD and cancer: The incubation with the SCD inhibitor also resulted in a profound reduction (∼60%) in the incorporation of [3H]thymidine into newly synthesized DNA, an early marker of cellular proliferation rate, in both A549 and H1299 cancer cell lines (Figure 1D and E).